Incyte(INCY.US)

Last Updated 19:00:00 ET
longbridge loading

Incyte Stock: Analyst Estimates & Ratings

Barchart Option·
US
INCY
+1.52%
US
LABD
-10.83%
US
IHE
+0.43%
Barchart Option·
US
INCY
+1.52%
US
LABD
-10.83%
US
IHE
+0.43%

Incyte CEO Says Post-Jakafi Growth Path Is Clearer as Pipeline Catalysts Build

Market Beat·
US
INCY
+1.52%
US
PBE
+0.89%
US
IBB
+1.75%
Market Beat·
US
INCY
+1.52%
US
PBE
+0.89%
US
IBB
+1.75%

Incyte Corp. Stock Underperforms Friday When Compared To Competitors

MarketWatch Automated·
US
INCY
+1.52%
MarketWatch Automated·
US
INCY
+1.52%

Incyte Corp. Stock Underperforms Thursday When Compared To Competitors

MarketWatch Automated·
US
INCY
+1.52%
US
PBE
+0.89%
US
LABU
+10.94%
MarketWatch Automated·
US
INCY
+1.52%
US
PBE
+0.89%
US
LABU
+10.94%

Incyte Corp. Stock Underperforms Tuesday When Compared To Competitors

MarketWatch Automated·
US
INCY
+1.52%
US
ARKG
+3.77%
US
BBH
+0.45%
MarketWatch Automated·
US
INCY
+1.52%
US
ARKG
+3.77%
US
BBH
+0.45%

Prelude Therapeutics Inc 1Q 2026: Revenue $4.58M, EPS $(0.13) — 10-Q Summary

TradingView·
US
PRLD
+3.04%
US
INCY
+1.52%
TradingView·
US
PRLD
+3.04%
US
INCY
+1.52%

Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress | INCY Stock News

StockTitan·
US
INCY
+1.52%
US
VHT
-0.09%
US
FBT
+1.49%
StockTitan·
US
INCY
+1.52%
US
VHT
-0.09%
US
FBT
+1.49%

Incyte Corp. Stock Outperforms Competitors On Strong Trading Day

MarketWatch Automated·
US
INCY
+1.52%
US
BBH
+0.45%
US
VHT
-0.09%
MarketWatch Automated·
US
INCY
+1.52%
US
BBH
+0.45%
US
VHT
-0.09%
© 2026 Longbridge｜Disclaimer